Reply to: "CardioMEMS in HF patients: study confirms benefit in costs and QALYs, but does not measure QALYs"

ESC Heart Fail. 2024 Aug;11(4):2475. doi: 10.1002/ehf2.14820. Epub 2024 Apr 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cost-Benefit Analysis*
  • Heart Failure* / economics
  • Heart Failure* / therapy
  • Humans
  • Quality-Adjusted Life Years*